Genus' (GNS) "Buy" Rating Reaffirmed at Shore Capital

Shore Capital reaffirmed their buy rating on shares of Genus (LON:GNS - Free Report) in a research note released on Tuesday morning, MarketBeat reports. Shore Capital currently has a GBX 2,750 ($36.93) price objective on the stock.

Genus Trading Down 0.8%

Shares of LON:GNS traded down GBX 20 ($0.27) on Tuesday, hitting GBX 2,400 ($32.23). The company had a trading volume of 126,212 shares, compared to its average volume of 239,371. The firm's 50-day simple moving average is GBX 2,064.03 and its two-hundred day simple moving average is GBX 1,876.20. Genus has a 1 year low of GBX 1,424 ($19.12) and a 1 year high of GBX 2,485 ($33.37). The company has a quick ratio of 1.08, a current ratio of 1.80 and a debt-to-equity ratio of 53.12. The firm has a market capitalization of £1.57 billion, a price-to-earnings ratio of 198.94, a P/E/G ratio of 2.87 and a beta of 0.37.

About Genus

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.